AKRX News and Press, Akorn Inc. From 05/04/20

Are These On Your List Of Penny Stocks to Watch Today? Penny stocks have been some of the best performers this year. Thanks in part to the coronavirus, cheap stocks have gone on to become industry competitors. Whether it is from the testing side or the vaccine niche, biotech penny stocks hav...

NEW YORK , April 27, 2020 /PRNewswire/ -- S&P Dow Jones Indices will make the following changes to the S&P MidCap 400 and S&P SmallCap 600 effective prior to the open of trading on Friday, May 1 : Enphase Energy Inc. (NASD:ENPH) will replace Core Laboratories N.V. (NY...

Enphase Energy (NASDAQ: ENPH ) is up 5.1% postmarket after news that it's replacing Core Laboratories (NYSE: CLB ) in the S&P MidCap 400 . More news on: Enphase Energy, Inc., Core Laboratories N.V., Akorn, Inc., Stocks on the move, Energy stocks news, Financial stocks news, Read...

Penny Stocks Taking Aim At COVID-19 Vaccines This week the conversation about coronavirus and, in turn, coronavirus penny stocks took a turn for the better. In his afternoon update, U.S. President Donald Trump explained that Gilead’s ( GILD ) Remdesivir had shown very promising result...

Akorn (NASDAQ: AKRX ) slips  20%  premarket on modest volume in reaction to its announcement  that it no longer has any potential bids to buy the company that are sufficient to pay all of its obligations under its term loan agreement, triggering an immediate default. More n...

LAKE FOREST, Ill. , April 1, 2020 /PRNewswire/ -- Akorn, Inc. (Nasdaq: AKRX), a leading specialty pharmaceutical company, today announced that it no longer has any bids in the Sale Process that are sufficient to pay all obligations under its term loan agreement. Accordingly, the Comp...

Akorn (NASDAQ: AKRX ): Q4 Non-GAAP EPS of -$0.07 misses by $0.06 ; GAAP EPS of -$0.64 misses by $0.39 . More news on: Akorn, Inc., Earnings news and commentary, Healthcare stocks news, , Read more ...

LAKE FOREST, Ill., Feb. 26, 2020 (GLOBE NEWSWIRE) -- Akorn, Inc. (Nasdaq: AKRX), a leading specialty pharmaceutical company, today announced its financial results for the quarter and year ended December 31, 2019. Fourth Quarter 2019 Results and Recent Developments Net revenue was $1...

XBiotech (NASDAQ: XBIT )  -26%  on preliminary results of tender offer . More news on: XBiotech Inc., Akorn, Inc., Catalyst Biosciences, Inc., Stocks on the move, , Read more ...

LAKE FOREST, Ill. , Feb. 12, 2020 /PRNewswire/ -- Akorn, Inc. (Nasdaq: AKRX), a leading specialty pharmaceutical company, today announced it has reached an agreement with certain of its lenders to extend the standstill period. The agreement defines a path forward and outlines&#x...